The Pharmacology of Citalopram Enantiomers: The Antagonism by R‐Citalopram on the Effect of S‐Citalopram*
- 8 August 2006
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 99 (2) , 91-95
Abstract
Recent results on the in vivo and in vitro pharmacology of escitalopram are summarised. The exact molecular mechanism by which R‐citalopram inhibits the effect of S‐citalopram on the serotonin transporter remains to be elucidated. Preliminary evidence indicates an effect of R‐citalopram on the association of escitalopram with the high affinity primary site, and on its dissociation from the serotonin transporter, via an allosteric mechanism. Escitalopram can be considered as an allosteric serotonin reuptake inhibitor. This serotonin dual action in binding to two sites on the serotonin transporter (both the primary site and the allosteric site) is hypothesised to be responsible for a longer binding to, and therefore greater inhibition of the serotonin transporter by escitalopram.Keywords
This publication has 33 references indexed in Scilit:
- Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorderInternational Clinical Psychopharmacology, 2005
- Efficacy of escitalopram in patients with severe depression: a pooled analysisInternational Journal Of Clinical Practice, 2005
- Identification and characterization of a novel allosteric modulator (SoRI‐6238) of the serotonin transporterSynapse, 2004
- Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake BlockadeNeuropsychopharmacology, 2004
- P.1.101 R-citalopram decreases the association of [3H]-S-citalopram with the human serotonin transporter by an allosteric mechanismEuropean Neuropsychopharmacology, 2003
- Escitalopram (S‐Enantiomer of Citalopram): Clinical Efficacy and Onset of Action Predicted from a Rat ModelBasic & Clinical Pharmacology & Toxicology, 2001
- Oligomerization of the Human Serotonin Transporter and of the Rat GABA Transporter 1 Visualized by Fluorescence Resonance Energy Transfer Microscopy in Living CellsJournal of Biological Chemistry, 2001
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal of Neural Transmission, 1992
- Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and plateletsEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranesLife Sciences, 1985